Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

BVMF/BALM3 stock hub

BVMF/BALM3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/BALM3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

215.3M

Brazil Stock Exchange

Market data

Price

Recent price action with selectable time range.

BVMF/BALM3BVMF/BALM3

—

Loading chart…

In the news

Latest news · BVMF/BALM3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E11.9

P25 n/aP50 n/aP75 n/a

ROE13.9

P25 n/aP50 n/aP75 n/a

ROIC27.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/BALM3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

BRL

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Brazil
Country code	BR
Employees	306
Enterprise value	BRL 160.4M
Exchange	Brazil Stock Exchange
Financial currency	BRL
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	BRBALMACNOR5
Last refreshed	2026-05-10
Market cap	BRL 215.3M
Price	BRL 25.18
Price currency	BRL
Rev Per Employee	698,460.78x
Sector	Healthcare
Sic	3842
Symbol	bvmf/BALM3
Website	https://www.baumer.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.39%
EV Earnings	8.88x
EV/EBIT	4.63x
EV/EBITDA	3.99x
EV/FCF	3.82x
EV/Sales	0.75x
FCF yield	19.51%
P/B ratio	1.5x
P/E ratio	11.91x
P/S ratio	1.01x
PE Ratio10 Y	22.95x
PE Ratio3 Y	10.02x
PE Ratio5 Y	12.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.46%
EBITDA Margin	21.05%
FCF margin	19.66%
Gross margin	63.23%
Gross Profit	BRL 135.1M
Gross Profit Growth	12.8%
Gross Profit Growth Q	0.41%
Gross Profit Growth3 Y	12.1%
Gross Profit Growth5 Y	10.63%
Net Income	BRL 18.1M
Net Income Growth	-42.81%
Net Income Growth Q	-45.17%
Net Income Growth Years	0%
Net Income Growth3 Y	46.62%
Net Income Growth5 Y	1.93%
Pretax Margin	13.96%
Profit Margin	8.46%
Profit Per Employee	BRL 59,075
Profitable Years	23
ROA	8.79
Roa5y	6.2
ROCE	21.13
ROE	13.88
Roe5y	10.19
ROIC	27.77
Roic5y	16.44

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	86.15%
Cagr3y	51.99%
Cagr5y	13.66%
Div CAGR10	28.21%
Div CAGR3	186.03%
Div CAGR5	50.81%
EPS Growth	-42.81
EPS Growth Q	-45.17
EPS Growth Years	0
EPS Growth3 Y	46.62
EPS Growth5 Y	1.93
FCF Growth	78.45%
FCF Growth Q	368.99%
FCF Growth5 Y	15.13%
OCF Growth	75.48%
OCF Growth Q	299.43%
OCF Growth10 Y	27.88%
OCF Growth3 Y	159.72%
OCF Growth5 Y	15.83%
Revenue Growth	9.95x
Revenue Growth Q	-9.52x
Revenue Growth Years	2x
Revenue Growth3 Y	9.11x
Revenue Growth5 Y	5.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.76
Assets	BRL 274.8M
Cash	BRL 67.3M
Current Assets	BRL 201.7M
Current Liabilities	BRL 88M
Debt	BRL 21.5M
Debt EBITDA	BRL 0.48
Debt Equity	BRL 0.15
Debt FCF	BRL 0.51
Equity	BRL 144M
Interest Coverage	1.61
Liabilities	BRL 130.8M
Long Term Assets	BRL 73.2M
Long Term Liabilities	BRL 42.8M
Net Cash	BRL 45.8M
Net Cash By Market Cap	BRL 21.28
Net Cash Growth	-23.75%
Net Debt EBITDA	BRL -1.02
Net Debt Equity	BRL -0.32
Net Debt FCF	BRL -1.09
Tangible Book Value	BRL 151.9M
Tangible Book Value Per Share	BRL 15.52
WACC	13.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.29
Inventory Turnover	1.2
Net Working Capital	BRL 49.1M
Quick ratio	1.51
Working Capital	BRL 113.6M
Working Capital Turnover	BRL 1.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	274.4%
Dividend Growth Years	1%
Dividend per share	BRL 4.68
Dividend Years	23
Dividend Yield	18.59%
Ex Div Date	2026-05-04
Last Dividend	BRL 0.82
Payout Frequency	Semi-Annual
Payout Ratio	337.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	86.07%
200-day SMA	14.22
3Y total return	251.19%
50-day SMA	22.2
50-day SMA vs 200-day SMA	50over200
5Y total return	89.64%
All Time High	35.4
All Time High Change	-28.87%
All Time High Date	2020-07-14
All Time Low	5.31
All Time Low Change	374.2%
All Time Low Date	2017-07-11
ATR	1.24
Beta	0.36
Ch YTD	-10.07
High	25.18
High52	33
High52 Date	2025-12-17
High52ch	-23.7%
Low	25.18
Low52	16.3
Low52 Date	2025-05-12
Low52ch	54.48%
Ma50ch	13.45%
Price vs 200-day SMA	77.07%
RSI	51.31
RSI Monthly	68.58
RSI Weekly	64.37
Sharpe ratio	1.3x
Sortino ratio	2.25
Total Return	18.59%
Tr YTD	-7.14

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 39.5M
Operating Income Growth	7.21
Operating Income Growth Q	-40.99
Operating Income Growth3 Y	30.2
Operating Income Growth5 Y	18.26
Operating margin	18.46

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,484,916%
Net Borrowing	4,773,000
Shares Insiders	38.46%
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 42M
Average Volume	305x
Bv Per Share	15.64
CAPEX	BRL -12.9M
Ch1m	-3.15
Ch1y	51.69
Ch3m	-3.15
Ch3y	154.3
Ch5y	34.01
Ch6m	20.48
Change	0%
Change From Open	0
Close	25.18
Days Gap	0
Depreciation Amortization	5,536,000
Dollar Volume	5,036
Earnings Date	2026-05-14
EBIT	BRL 39.5M
EBITDA	BRL 45M
EPS	BRL 1.85
F Score	6
FCF	BRL 42M
FCF EV Yield	26.19x
Financing CF	-56,277,000
Fiscal Year End	December
Founded	1,952
Graham Number	28.29875
Graham Upside	12.39
Income Tax	BRL 7.7M
Investing CF	-8,110,000
Is Primary Listing	0
Last Earnings Date	2025-11-11
Last Report Date	2025-12-31
Last Split Date	2014-05-02
Last Split Type	Forward
Lynch Fair Value	BRL 10.57
Lynch Upside	-58.03
Ma150	15.42
Ma150ch	63.27%
Ma20	26
Ma20ch	-3.16%
Net CF	-9,500,000
Next Earnings Date	2026-05-14
Open	25.18
P FCF Ratio	5.13
P OCF Ratio	3.92
Payment Date	2026-12-30
Ppne	41,062,000
Price Date	2026-05-06
Price EBITDA	BRL 4.79
Ptbv Ratio	1.42
Relative Volume	0.66x
Revenue	213,729,000x
Tax By Revenue	3.62x
Tax Rate	25.93%
Tr6m	37.16%
Volume	200
Z Score	2.94

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/BALM3 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+18.6%

$4.68 annual per share

Payout ratio

+337.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+50.8%

1 consecutive years of growth

Total shareholder yield

+18.6%

Next ex-dividend date: 2026-05-04

Performance

BVMF/BALM3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/BALM3?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+38.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

BVMF/BALM3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.3

Neutral momentum band

Price vs 200-day MA

+77.1%

50/200-day relationship not available

Beta (5Y)

0.36

Less volatile than the market

Sharpe ratio

1.30

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/BALM3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/BALM3 stock rating?

bvmf/BALM3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/BALM3 analysis?

The full report lives at /stocks/bvmf/BALM3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/BALM3?

The latest report frames bvmf/BALM3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/BALM3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.